Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG) - A widespread protein superfamily

被引:120
作者
Jakobsson, PJ [1 ]
Morgenstern, R
Mancini, J
Ford-Hutchinson, A
Persson, B
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys MBB, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden
[3] Merck Frosst Ctr Therapeut Res, Kirkland, PQ, Canada
关键词
D O I
10.1164/ajrccm.161.supplement_1.ltta-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The members of the MAPEG superfamily have been aligned and found to be distantly related (1), with a common pattern of hydropathy (1). Figure 2A shows the multiple sequence alignments of the human members and Figure 2B the corresponding superimposed hydropathy profiles. The alignment in Figure 2A demonstrates a total of six strictly conserved residues. The Arg-51 in LTC4 synthase has been suggested to function as a proton donor for the opening of the LTA4 epoxide (29). This arginine is found in all but the FLAP sequences, in accordance with the observation that FLAP has no known enzyme activity. Also, the Tyr-93 in LTC4 synthase has been suggested to function as a base for the formation of the thiolate anion of glutathione. This tyrosine is not conserved in MGST1 or MGST1-L1. Table 1 summarizes some other properties of the individual human proteins. They are all of the same size, ranging from 147 to 161 amino acids. Only FLAP differs, in that its isoelectric point is more neutral than that of the other, more basic proteins. The genes encoding these proteins all reside on different chromosomes (when known) (Table 1). In addition to the human proteins, MAPEG members have been identified in plants, fungi, and bacteria. It is clearly a challenge to elucidate their role in these different phyla in relation to their defined physiological functions in humans.
引用
收藏
页码:S20 / S24
页数:5
相关论文
共 45 条
[1]   5-LIPOXYGENASE-ACTIVATING PROTEIN STIMULATES THE UTILIZATION OF ARACHIDONIC-ACID BY 5-LIPOXYGENASE [J].
ABRAMOVITZ, M ;
WONG, E ;
COX, ME ;
RICHARDSON, CD ;
LI, C ;
VICKERS, PJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 215 (01) :105-111
[2]  
Andersson C, 1994, Adv Pharmacol, V27, P19, DOI 10.1016/S1054-3589(08)61028-5
[3]   HUMAN-ENDOTHELIAL CELLS STIMULATE LEUKOTRIENE SYNTHESIS AND CONVERT GRANULOCYTE RELEASED LEUKOTRIENE-A4 INTO LEUKOTRIENE-B4, LEUKOTRIENE-C4, LEUKOTRIENE-D4 AND LEUKOTRIENE-E4 [J].
CLAESSON, HE ;
HAEGGSTROM, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 173 (01) :93-100
[4]  
COFFEY M, 1992, J BIOL CHEM, V267, P570
[5]   Pharmacological characterization of leukotriene receptors [J].
Dahlén, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (02) :S41-S45
[6]   REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS [J].
DIXON, RAF ;
DIEHL, RE ;
OPAS, E ;
RANDS, E ;
VICKERS, PJ ;
EVANS, JF ;
GILLARD, JW ;
MILLER, DK .
NATURE, 1990, 343 (6255) :282-284
[7]  
Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
[8]   L-663,536 (MK-886) (3-[1-(4-CHLOROBENZYL)-3-T-BUTYL-THIO-5-ISOPROPYLINDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID), A NOVEL, ORALLY ACTIVE LEUKOTRIENE BIOSYNTHESIS INHIBITOR [J].
GILLARD, J ;
FORDHUTCHINSON, AW ;
CHAN, C ;
CHARLESON, S ;
DENIS, D ;
FOSTER, A ;
FORTIN, R ;
LEGER, S ;
MCFARLANE, CS ;
MORTON, H ;
PIECHUTA, H ;
RIENDEAU, D ;
ROUZER, CA ;
ROKACH, J ;
YOUNG, R ;
MACINTYRE, DE ;
PETERSON, L ;
BACH, T ;
EIERMANN, G ;
HOPPLE, S ;
HUMES, J ;
HUPE, L ;
LUELL, S ;
METZGER, J ;
MEURER, R ;
MILLER, DK ;
OPAS, E ;
PACHOLOK, S .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (05) :456-464
[9]  
HILL E, 1992, J BIOL CHEM, V267, P22048
[10]   Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities [J].
Jakobsson, PJ ;
Mancini, JA ;
Riendeau, D ;
FordHutchinson, AW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22934-22939